Emergent Broadens Bioterror Offering In $125m Sanofi Smallpox Vaccine Buy

 
• By Sten Stovall
Smallpox
Sanofi Is Divesting Its Smallpox Vaccine To Focus On "Current and Emerging" Disease • Source: Shutterstock

More from Deals

More from Business